We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genetic Tests Could Indicate Personality Disorder

By Biotechdaily staff writers
Posted on 20 Mar 2007
Genetic tests using blood samples are already used to diagnose some diseases and even personalize treatment. More...
It is possible to develop similar tests that reveal a person's potential to become dependent on nicotine or marijuana or have an antisocial personality disorder.
These tests would not dictate who would become substance dependent or have behavioral problems, as genes do not function in isolation, but are influenced by other genes and environmental factors. In a recent study, the researchers found certain differences in the genes of people with a history of smoking compared to those without such a history. In all, 579 genes were more expressed and 584 genes were less expressed in people who had smoked.
The technique used to analyze blood is called transcriptional profiling, said Anup Madan, UI adjunct assistant professor of neurosurgery and an assistant professor at the Institute of Systems Biology in Seattle (WA, USA). Transcription profiling involves looking at all the genes--nearly 30,000 of them--at one time. We label all the expressed genes by fluorescent tags, and changes in fluorescence intensity are used to identify differential gene expression.
The study was reported by University of Iowa (UI; Iowa City, IA, USA) scientists in the March 6, 2007, online edition of the American Journal of Molecular genetics. Our study suggests that analyzing the expression of genes in blood could indicate whether a person is susceptible to having a behavioral disorder. Having a particular gene expression change does not by itself predict that a person will act a certain way. However, it can indicate who might have a greater biological basis for engaging in behaviors such as smoking and alcohol or marijuana use, said the study's lead author Robert Philibert, M.D., Ph.D., professor of psychiatry in the UI Roy J. and Lucille A. Carver College of Medicine. What matters most is not whether you have a particular gene but whether the gene is expressed, and what other environmental factors may be at play. Genetic variation in and of itself is not deterministic, he added.
Our study suggests that analyzing the expression of genes in blood could indicate whether a person is susceptible to having a behavioral disorder. Having a particular gene expression change does not by itself predict that a person will act a certain way. However, it can indicate who might have a greater biologic basis for engaging in behaviors such as smoking and alcohol or marijuana use, Professor Philibert said.


Related Links:
Institute of Systems Biology in Seattle
University of Iowa

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Hematology Consumables
Bioblood Devices
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.